ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 82 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,188 | -14.4% | 6,375 | 0.0% | 0.00% | – |
| Q2 2022 | $3,724 | -18.0% | 6,375 | 0.0% | 0.00% | – |
| Q1 2022 | $4,539 | -46.1% | 6,375 | 0.0% | 0.00% | – |
| Q4 2021 | $8,415 | -57.8% | 6,375 | -26.5% | 0.00% | -100.0% |
| Q3 2021 | $19,953 | -50.5% | 8,675 | -5.4% | 0.00% | -50.0% |
| Q2 2021 | $40,278 | -36.0% | 9,175 | +5.8% | 0.00% | -33.3% |
| Q1 2021 | $62,981 | +190.1% | 8,675 | +72.6% | 0.00% | +200.0% |
| Q4 2020 | $21,708 | -12.3% | 5,025 | -16.6% | 0.00% | 0.0% |
| Q3 2020 | $24,763 | +103.8% | 6,025 | +197.5% | 0.00% | 0.0% |
| Q2 2020 | $12,150 | +43.4% | 2,025 | +80.0% | 0.00% | 0.0% |
| Q1 2020 | $8,471 | -45.2% | 1,125 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $15,469 | +48.8% | 1,125 | +28.6% | 0.00% | 0.0% |
| Q3 2019 | $10,395 | -15.1% | 875 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,241 | – | 875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |